Oxycodone and Daklinza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone (oxycodone hydrochloride) and Daklinza (daclatasvir dihydrochloride). Common drug interactions include fatigue among females and hepatorenal syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone and Daklinza. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.

What is Daklinza?

Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,312 Daklinza users. Check the latest studies of Daklinza.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

19 people who take Oxycodone and Daklinza together, and have interactions are studied.

Oxycodone and Daklinza drug interactions.

What are the common drug interactions of Oxycodone and Daklinza, by gender? *:

female:

Fatigue (feeling of tiredness)
Headache (pain in head)
Vision blurred
Epistaxis (bleed from the nose)
Muscular weakness (muscle weakness)
Myalgia (muscle pain)
Pain in extremity
Photosensitivity reaction
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Sinusitis (inflammation of sinus)

male:

Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
Pneumonia
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gynaecomastia (enlargement of the gland tissue of the male breast)
Haemolytic anaemia (anaemia due to haemolysis)
Hepatorenal failure (decrease in kidney function in a person with a severe liver disorder)
Hypertension (high blood pressure)
Inflammation

What are the common drug interactions of Oxycodone and Daklinza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Septic shock (shock due to blood infection)

50-59:

Hepatorenal failure (decrease in kidney function in a person with a severe liver disorder)
Inflammation
Irritability
Leukocytosis (increased white blood cells)
Muscular weakness (muscle weakness)
Myalgia (muscle pain)
Pain in extremity
Photosensitivity reaction
Pneumonia
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

60+:

Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Occult blood positive

What are the existing conditions these people have? *

Hepatitis C: 12 people, 63.16%
Hiv Infection: 4 people, 21.05%
Hiv Test Positive: 2 people, 10.53%
Stress And Anxiety: 1 person, 5.26%
Renal Disorder (kidney disease): 1 person, 5.26%
Nausea And Vomiting: 1 person, 5.26%
Nausea (feeling of having an urge to vomit): 1 person, 5.26%
Dyspnea (difficult or laboured breathing): 1 person, 5.26%
Chronic Hepatitis (long lasting inflammation of liver): 1 person, 5.26%
Acute Leukaemia (blood cancer): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone and Daklinza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously